In a pivotal move in procurement and supply chain management, the European Union is set to restrict Chinese medical device manufacturers from accessing public procurement contracts across the bloc. The proposed measure expected to be voted on by EU member states as early as Monday marks the first use of the International Procurement Instrument, a 2022 law aimed at ensuring reciprocal access to global procurement markets. This shift is a major development in the procurement supply chain and logistics ecosystem, particularly in the healthcare sector. The EU's investigation, launched in April last year, found that China had created discriminatory barriers against foreign medical device companies. With negotiations failing, the bloc is now moving forward with regulatory action. China's tightening of local procurement rules has dramatically